Contents

James C. Tsai

This article is about the ophthalmologist. For the politician, see James Tsai.

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This biographical article is written like a résumé. Please help improve it by revising it to be neutral and encyclopedic. (February 2021) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (February 2021) (Learn how and when to remove this message) (Learn how and when to remove this message)

James C. Tsai
Born	1963
Education	Amherst College, Stanford University School of Medicine, Owen Graduate School of ManagementatVanderbilt University
Medical career
Profession	Ophthalmologist
Institutions	Vanderbilt University School of Medicine, Harkness Eye Institute at Columbia University College of Physicians and Surgeons, Yale University School of Medicine, New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount Sinai
Sub-specialties	Glaucoma and glaucoma surgery
Website	James C. Tsai at Mount Sinai

James C. Tsai is a physician and scientist who serves as president of the New York Eye and Ear Infirmary of Mount Sinai.^[1][2][3] He also serves as the Delafield-Rodgers Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai and chair of the department of ophthalmology at the Mount Sinai Health System.

Tsai published the first taxonomy of medication compliance and adherence barriers in patients with glaucoma, the initial paper describing the isolated-check visual evoked potential technology for patients with glaucoma,^[4] and one of the first studies evaluating the use of erythropoietin for neuroprotection in an animal model of glaucoma.

Biography[edit]

A 1981 graduate of Phillips Exeter Academy, Tsai received his B.A. in neuroscience, magna cum laude, from Amherst College in 1985, his M.D. from Stanford University School of Medicine in 1989, and his M.B.A. in 1998 from the Owen Graduate School of ManagementatVanderbilt University. He served his residency in ophthalmology at Doheny Eye Institute at the University of Southern California, 1990–1993, his fellowship in glaucoma at Bascom Palmer Eye Institute, University of Miami, 1993–1994, and another fellowship in glaucoma at Moorfields Eye Hospital and the Institute of Ophthalmology, London, 1994–1995.

Former positions include assistant professor of ophthalmology and visual sciences and residency program director, department of ophthalmology and visual sciences at Vanderbilt University School of Medicine,^[5] as well as associate professor of ophthalmology and director, glaucoma division, department of ophthalmology, Edward S. Harkness Eye Institute, Columbia University College of Physicians and Surgeons.^[1]

Tsai then served as the inaugural Robert R. Young Professor of Ophthalmology and Visual Science and chair, department of ophthalmology and visual science, Yale University School of Medicine^[6] and chief of ophthalmology, Yale-New Haven Hospital.^[7]

Research[edit]

Tsai's research includes the identification of neuroprotective molecules that can shield the optic nerve from damage without lowering intraocular pressure, evaluation of medical adherence and surgical outcomes in patients with glaucoma, and development of advanced vision testing techniques.^[8]

His more recent research^[when?] includes the long-term safety and efficacy of the Ahmed shunt versus the Baerveldt shunt implant, optimizing and enhancing medication adherence in patients with glaucoma, and understanding the role of inflammation in the pathogenesis and treatment of glaucoma.^{[9][10][11][12]}

Publications[edit]

Author of more than 100 peer-reviewed scientific articles and over 80 invited medical articles, book chapters, and textbooks, including the Oxford American Handbook of Ophthalmology and Medical Management of Glaucoma (4 editions).^[13][14] Tsai has served as editorial board member for 9 medical journals and manuscript reviewer for over 100 additional scientific publications.

His most cited journal articles are:

• Sivak-Callcott, JA; O'Day, DM; Gass, JD; Tsai, JC (Oct 2001). "Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma". Ophthalmology. 108 (10): 1767–76. doi:10.1016/s0161-6420(01)00775-8. PMID 11581047. (cited 373 times according to GoogleScholar ^[15])
• Tsai, JC; McClure, CA; Ramos, SE; Schlundt, DG; Pichert, JW (2003). "Compliance Barriers in Glaucoma: A Systematic Classification". J Glaucoma. 12 (5): 393–8. doi:10.1097/00061198-200310000-00001. PMID 14520147. S2CID 33703059. (cited 333 times according to GoogleScholar ^[15])
• Bloom, PA; Tsai, JC; Sharma, K; Miller, MH; Rice, NS; Hitchings, RA; Khaw, PT (Sep 1997). ""Cyclodiode": Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma". Ophthalmology. 104 (9): 1508–20. doi:10.1016/S0161-6420(97)30109-2. PMID 9307649. (cited 310 times according to GoogleScholar^[15])
• Salchow, DJ; Oleynikov, YS; Chiang, MF; Kennedy-Salchow, SE; Langton, K; Tsai, JC; Al-Aswad, LA (May 2006). "Retinal nerve fiber layer thickness in normal children measured with optical coherence tomography". Ophthalmology. 113 (5): 786–91. doi:10.1016/j.ophtha.2006.01.036. PMID 16650674. (cited 175 times according to GoogleScholar^[15])
• Tsai, JC; Johnson, CC; Dietrich, MS (Sep 2003). "The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a single-surgeon comparison of outcome". Ophthalmology. 110 (9): 1814–21. doi:10.1016/s0161-6420(03)00574-8. PMID 13129882. (cited 194 times according to GoogleScholar^[15])

References[edit]

External links[edit]

• Mount Sinai profile page